Neuropathix Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of NPTX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies6,518,0956.67%
VC/PE Firms6,817,0676.98%
Public Companies20,342,07620.8%
Individual Insiders25,918,80926.5%
General Public38,102,39639%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 10 shareholders own 61% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.8%
Medical Marijuana, Inc.
20,342,076US$6.1k0%no data
17%
Dean Petkanas
16,640,934US$5.0k0%no data
6.98%
Kettner Investments, LLC
6,817,067US$2.0k0%100.0%
6.67%
Golden Gate Capital Partners LLC
6,518,095US$2.0k0%no data
5.58%
Thomas Kikis
5,454,125US$1.6k0%no data
1.58%
Mark Corrao
1,546,875US$464.10%no data
1.56%
William Kinney
1,526,875US$458.10%no data
0.26%
Robert Malasek
250,000US$75.00%no data
0.26%
Timothy Scott
250,000US$75.00%no data
0.26%
Blake Schroeder
250,000US$75.00%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.